Answers are grounded in this paper and cite their sources.
Lung cancer stands as a leading cause of cancer-related deaths worldwide, with a high mortality rate due to late-stage metastasis. The epithelial-mesenchymal transition (EMT) process plays a crucial role in cancer progression, contributing to the invasive and metastatic traits observed in lung cancer. Antrodia cinnamomea , a Taiwanese mushroom, has shown diverse biological activities including hepatoprotection and anti-inflammatory responses, as well as anticancer properties. However, research on its efficacy against lung cancer metastasis is limited. In current study, we found the potential of Antcin K, a predominant compound in Antrodia cinnamomea , to inhibit the migratory potential of lung cancer cells. Firstly, the cell viability assay was used to explore the cytotoxicity effect of Antcin K in A549 and CL1-0 lung cancer cells. The results showed that Antcin K had no cytotoxicity effect under 40 µM. We investigated the anti-EMT potential of Antcin K in lung cancer cells, and results showed that pretreatment with Antcin K dramatically inhibited transforming growth factor-beta (TGF-β)-induced mesenchymal-like change of lung cancer cells. Furthermore, pre-treatment with Antcin K also abolished cell migration ability in response to TGF-β stimulation. Finally, we found Antcin K could reduce vimentin expression in response to TGF-β stimulation in lung cancer cells. In summary, our current study highlights the potential of Antcin K to prevent metastasis of lung cancer by targeting EMT, offering a novel therapeutic approach for lung cancer treatment.
No takes yet. Share an insight, caveat, or question.
Hsiao et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: